Insider · CIK 0001296965
Kristen Williams
Files at PCRX (Pacira BioSciences, Inc.). First filing Jun 5, 2025, latest Jun 5, 2026.
In brief
Kristen Williams files SEC Form 4 as officer at PCRX (Pacira BioSciences, Inc.). Since Jun 5, 2025, Kristen Williams has reported 0 open-market buys worth $0 and 3 open-market sells worth $875k, the latest filed on Jun 5, 2026.
A track record needs three past buys with six months of prices behind them; Kristen Williams has 0, so none is measured yet.
The newest scored trade: sold $228k of PCRX on Jun 4, 2026, filed Jun 5, 2026, scored 16 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $498k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
PCRX: Pacira BioSciences, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | Pacira BioSciences, Inc. | $228k 10,259 shares | -6% | +18% from low-17% from high | |
| 16Weak | Pacira BioSciences, Inc. | $270k 13,137 shares | -9% | +11% from low-22% from high | |
| 39Weak | Pacira BioSciences, Inc. | $377k 14,376 shares | -8% | +112% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 4, 2026 | PCRX Pacira BioSciences, Inc. | 10,259 0.03% of outstanding | $228k | Jun 4, 2026 | none |
| Feb 2, 2026 | PCRX Pacira BioSciences, Inc. | 13,137 0.03% of outstanding | $270k | Feb 2, 2026 | none |
| Jun 4, 2025 | PCRX Pacira BioSciences, Inc. | 14,376 0.03% of outstanding | $377k | Jun 4, 2025 | none |
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | PCRX Pacira BioSciences, Inc. | FTax withholding Common Stock10b5-1 | -8,528 | $22.32 | $190k | 177,321 | Jun 5, 2026 |
| Jun 4, 2026 | PCRX Pacira BioSciences, Inc. | SOpen-market sale Common Stock10b5-1 | -10,259 | $22.27 | $228k | 167,062 | Jun 5, 2026 |
| Feb 11, 2026 | PCRX Pacira BioSciences, Inc. | AGrant or award Common Stock | +54,546 | $0.00 | $0 | 185,849 | Feb 13, 2026 |
| Jan 30, 2026 | PCRX Pacira BioSciences, Inc. | FTax withholding Common Stock10b5-1 | -17,134 | $20.54 | $352k | 144,440 | Feb 3, 2026 |
| Feb 2, 2026 | PCRX Pacira BioSciences, Inc. | SOpen-market sale Common Stock10b5-1 | -13,137 | $20.53 | $270k | 131,303 | Feb 3, 2026 |
| Jun 3, 2025 | PCRX Pacira BioSciences, Inc. | FTax withholding Common Stock | -6,162 | $26.40 | $163k | 175,950 | Jun 5, 2025 |
| Jun 4, 2025 | PCRX Pacira BioSciences, Inc. | SOpen-market sale Common Stock | -14,376 | $26.24 | $377k | 161,574 | Jun 5, 2025 |
Questions about Kristen Williams
Answered from the filings on this page, as of the latest one.
Is Kristen Williams buying or selling?
In the last 12 months Kristen Williams reported 0 open-market buys worth $0 and 2 open-market sells worth $498k on SEC Form 4; the latest was sold $228k of PCRX on Jun 4, 2026. Grants, option exercises and tax withholding are not counted.
How did Kristen Williams's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kristen Williams has 0.
Where does Kristen Williams file Form 4?
Kristen Williams has filed Form 4 at PCRX (Pacira BioSciences, Inc.) as Chief Administrative Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.